← All posts / Industry

Unitree's 45% Post-IPO Slump Sparks Bubble Fears in China's Robotics Boom

Unitree shares have lost 45% since their 460% first-day surge in Shanghai, erasing roughly $30 billion and igniting a debate over froth, retail losses and China's IPO pricing system.

Unitree's 45% Post-IPO Slump Sparks Bubble Fears in China's Robotics Boom

Five trading days. That is all it took for Unitree, China’s best-known humanoid robot maker, to go from the most euphoric stock debut in Shanghai’s history to a case study in bubble dynamics. Shares of the company — which had surged more than fivefold on their first day of trading last Wednesday, briefly valuing it at roughly $66 billion — have now fallen about 45% from that peak, wiping out close to $30 billion in market value. On Tuesday, the stock finally steadied after three consecutive sessions of decline, but the damage to sentiment had already been done.

The reversal, reported by Reuters on August 25, has triggered exactly the kind of soul-searching that Chinese regulators had hoped to avoid. Concerns are now centering on three intertwined issues: whether enthusiasm for AI and robotics has outpaced fundamentals, whether small retail investors have been burned by a listing mechanism that some analysts say distorts prices, and whether the broader “self-sufficiency” rally in Chinese hard-tech can survive contact with profit-and-loss statements.

From 460% Pop to Painful Reversal

The numbers behind Unitree’s wild ride are worth spelling out. The company priced its Shanghai STAR Market IPO at 150.8 yuan (about $22.34) per share, valuing it at roughly 61 billion yuan, or around $9 billion. Retail demand was extraordinary — the offering was reported to be more than 8,000 times oversubscribed, the largest oversubscription in STAR Market history. When trading began on August 19, the stock closed the day up around 460%, having at one point traded as high as 1,100 yuan.

To put that in perspective, the average first-day gain for newly listed stocks in China over the past three years is 226%. Unitree’s debut was more than double that, and at its intraday peak it carried a market capitalization of about $66 billion — an extraordinary figure for a company that reported just 40 million yuan (about $5.95 million) in adjusted net profit in the first three months of 2026, a figure that was itself down 53% year-over-year.

Then came the reckoning. Three straight sessions of decline took cumulative losses to 45% from the debut close. Even after the selloff, the company remains valued at a multiple that assumes years of flawless execution in commercializing robots whose most famous public feats so far involve running, dancing and performing martial arts.

A Fundamentals Problem

The bear case on Unitree is not really about the technology. The company is one of the world’s largest producers of quadruped and humanoid robots, a genuine engineering achievement, and it competes globally with Tesla and Hyundai-owned Boston Dynamics. The problem is commercial traction. Unitree has had little success so far in broader commercial applications: its own filings show that a large majority of 2025 robot revenue — over 70% — still came from research and education customers rather than industrial deployment.

“Investors were carried away by the technology revolution narrative,” Dong Baozhen, chairman of Beijing-based asset manager Lingtong Shengtai, told Reuters, adding the warning that “all bubbles are doomed to burst.”

That tension — between a real technology revolution and prices that assume the revolution arrives on schedule — is now playing out across China’s robotics sector. Unitree’s debut was supposed to set the tone for a slate of domestic rivals preparing to come to market. Instead, it may become a cautionary tale for other Chinese tech companies hoping to ride Beijing’s “self-sufficiency” drive to a public listing.

Questions About the Listing System

The more uncomfortable part of the story is structural. Several of the investors and bankers quoted in the Reuters report argue that Unitree’s boom-and-bust was not simply organic market enthusiasm but a predictable artifact of how China’s IPO system works.

Abraham Zhang, chairman of venture capital firm China Europe Capital, was blunt about it: the debut performance “was not fuelled by a rosy prospect, but a desire by some to pump up the shares so as to dump them later at lofty prices.” Loopholes in the listing system, he argued, have allowed major shareholders to cash in while shifting risk onto mom-and-pop investors in secondary-market trades.

Three mechanisms amplify the problem. First, Chinese exchanges not only vet listing candidates but also give guidance on IPO pricing, limiting bankers’ ability to price deals in line with feverish demand — which is how a $9 billion company can open at a $66 billion valuation. Second, short-selling is heavily restricted, so overpriced listings face no immediate corrective pressure from traders betting against them. Hedge fund manager Yuan Yuwei of Trinity Synergy Investments noted that pump-and-dump dynamics in new listings become possible precisely because of this: “An IPO stock worth 10 yuan can open at 100 yuan, before sliding for years. It’s a rip-off.”

Third, there is the scarcity factor. Only 21 companies went public in Shanghai during the first seven months of the year, versus 104 in Hong Kong, a consequence of tight regulatory scrutiny of new listings. Investors starved of hard-tech exposure in the domestic market piled into the few names that made it through the gate — Unitree, and before it the DRAM maker CXMT, which soared 466% in its own Shanghai debut last month. “There are not many good companies in China’s stock market,” as Yuan put it.

A Retail Reckoning

The human cost is already visible. A retail investor who lost money on Unitree wrote in a blog post that he supports Chinese innovation, but that “the rapid concentration of wealth cannot be built on the pains of retail investors.” Those who won allocations in the IPO “walked away with smiles,” in Zhang’s words, while many small investors who bought the post-debut hype were left holding the losses.

Dong of Lingtong Shengtai pointed to the staggering gap between the IPO price and the first-day close as evidence that something in the price discovery chain is broken: “either one of them must be wrong,” and in his view it was the latter — the debut was the mispriced leg. “Debut performance is the barometer of market mood, and exuberant mood breeds bubbles.”

Not Everyone Is Bearish

The bull case has not disappeared, and it deserves a fair hearing. Gao Xingkun, a fund manager at China Southern Asset Management, argues that robotics investors need patience: “Many robot makers spend a lot on research, but commercial orders are not yet in sight. It’s not fair if you only look at profit.” He draws a parallel to China’s electric vehicle industry, which burned through years of losses and skepticism before becoming a global force — a reminder that today’s thin profits do not necessarily doom a strategically important sector.

The uncomfortable counterpoint is that EV makers eventually earned their valuations with unit economics that scaled. Humanoid robotics has not yet shown an equivalent path, and a company whose valuation briefly touched $66 billion while quarterly profit sits near $6 million has a long way to fall — or a very long way to grow — before the two numbers reconcile.

Why It Matters Beyond China

For global observers, Unitree’s whiplash matters for two reasons. It is a real-time stress test of how capital markets absorb the AI-and-robotics narrative when it collides with reported earnings — a preview of debates likely to repeat wherever humanoid-robot companies go public. And it complicates Beijing’s balancing act: the state wants strategic industries funded generously, but not at the cost of a retail-investor backlash that undermines confidence in the STAR Market itself.

The stock may have steadied on Tuesday, but as Zhang noted, “the capital drama seen in the Unitree listing is not the first in China, and will not be the last.” The lesson from Unitree’s first five days as a public company is less about robots than about markets: when a listing system caps the IPO price, restricts short-selling, and funnels national-strategy euphoria into a scarce float, the result is a valuation that behaves less like an asset price and more like a mood ring. This week, the mood turned.